<h4 style="text-align: center;">Stage 3 (Internal Development) - Safety</h4>
<style>body { font-family: Arial, sans-serif; font-size: 14px; } .table { border-collapse: collapse; width: 60%; margin: auto; } th, td { padding: 10px; text-align: center; background-color: #f2f2f2; } th:first-child, td:first-child { text-align: left; } td { font-size: 12px; } th { font-size: 12px; } h2 { font-size: 14px; }</style>

<table border="0" class="dataframe table">
  <thead>
    <tr style="text-align: right;">
      <th></th>
      <th>count</th>
      <th>mean</th>
      <th>std</th>
      <th>min</th>
      <th>35%</th>
      <th>50%</th>
      <th>max</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <th>Verification and validation (V&amp;V) activities should be targeted towards the safety-critical nature of health AI technologies</th>
      <td>20</td>
      <td>4.55</td>
      <td>0.76</td>
      <td>3</td>
      <td>5</td>
      <td>5</td>
      <td>5</td>
    </tr>
    <tr>
      <th>Verification and validation activities should be targeted towards the safety-critical nature of health AI technologies</th>
      <td>20</td>
      <td>4.50</td>
      <td>0.76</td>
      <td>3</td>
      <td>5</td>
      <td>5</td>
      <td>5</td>
    </tr>
    <tr>
      <th>Ensure that responsibility for the oversight of safety rests high enough in the health system</th>
      <td>20</td>
      <td>4.50</td>
      <td>0.69</td>
      <td>3</td>
      <td>4</td>
      <td>5</td>
      <td>5</td>
    </tr>
    <tr>
      <th>Assess whether the initial deployment of this technology falls under the category of human subjects research</th>
      <td>20</td>
      <td>4.50</td>
      <td>0.83</td>
      <td>3</td>
      <td>5</td>
      <td>5</td>
      <td>5</td>
    </tr>
    <tr>
      <th>Conduct an assessment to ensure compliance with federal regulations</th>
      <td>20</td>
      <td>4.45</td>
      <td>0.89</td>
      <td>3</td>
      <td>5</td>
      <td>5</td>
      <td>5</td>
    </tr>
    <tr>
      <th>Using a risk-based approach to patient safety, plan methods for risk management and assessment</th>
      <td>20</td>
      <td>4.40</td>
      <td>0.82</td>
      <td>3</td>
      <td>4</td>
      <td>5</td>
      <td>5</td>
    </tr>
    <tr>
      <th>Maintain a monitoring process for adverse events and serious adverse events</th>
      <td>20</td>
      <td>4.40</td>
      <td>0.82</td>
      <td>3</td>
      <td>4</td>
      <td>5</td>
      <td>5</td>
    </tr>
    <tr>
      <th>Ensure that AI models are labeled with transparent information about their development</th>
      <td>20</td>
      <td>4.35</td>
      <td>0.75</td>
      <td>3</td>
      <td>4</td>
      <td>4</td>
      <td>5</td>
    </tr>
    <tr>
      <th>Ensure that stakeholders involved in the development, testing, and deployment of health AI are trained on ethics</th>
      <td>20</td>
      <td>4.25</td>
      <td>0.79</td>
      <td>3</td>
      <td>4</td>
      <td>4</td>
      <td>5</td>
    </tr>
    <tr>
      <th>Ensure that automation bias is mitigated by keeping humans in the loop and implementing quality control measures</th>
      <td>20</td>
      <td>4.25</td>
      <td>0.79</td>
      <td>3</td>
      <td>4</td>
      <td>4</td>
      <td>5</td>
    </tr>
    <tr>
      <th>Consider ethical and legal challenges and how they will be handled</th>
      <td>20</td>
      <td>4.20</td>
      <td>0.89</td>
      <td>3</td>
      <td>4</td>
      <td>4</td>
      <td>5</td>
    </tr>
    <tr>
      <th>Backup processes must be available for workflow without the health AI technology incorporated</th>
      <td>20</td>
      <td>4.15</td>
      <td>0.88</td>
      <td>3</td>
      <td>4</td>
      <td>4</td>
      <td>5</td>
    </tr>
    <tr>
      <th>Maintain document control and records management to help communicate and preserve the rationale behind decisions</th>
      <td>20</td>
      <td>4.10</td>
      <td>0.79</td>
      <td>3</td>
      <td>4</td>
      <td>4</td>
      <td>5</td>
    </tr>
    <tr>
      <th>Maintain a clear layout of roles and accountability, involving all stakeholders and independent audits</th>
      <td>20</td>
      <td>4.10</td>
      <td>0.72</td>
      <td>3</td>
      <td>4</td>
      <td>4</td>
      <td>5</td>
    </tr>
    <tr>
      <th>Ensure public transparency on validation methods and results</th>
      <td>20</td>
      <td>4.05</td>
      <td>0.94</td>
      <td>2</td>
      <td>4</td>
      <td>4</td>
      <td>5</td>
    </tr>
    <tr>
      <th>Ensure that an impact analysis plan is in place for any health AI changes</th>
      <td>20</td>
      <td>4.00</td>
      <td>0.79</td>
      <td>3</td>
      <td>4</td>
      <td>4</td>
      <td>5</td>
    </tr>
    <tr>
      <th>Workforce training should be developed around the use, risks, limitations and implications of AI technology</th>
      <td>20</td>
      <td>4.00</td>
      <td>0.65</td>
      <td>3</td>
      <td>4</td>
      <td>4</td>
      <td>5</td>
    </tr>
    <tr>
      <th>Provide clarity to users that no bug fixes, updates, patches, or technical support will be available once end-of-life is signed-off</th>
      <td>20</td>
      <td>3.85</td>
      <td>0.99</td>
      <td>2</td>
      <td>4</td>
      <td>4</td>
      <td>5</td>
    </tr>
    <tr>
      <th>Define a workflow that ties to the training material, and consider the ramification of “off-label” workflows</th>
      <td>20</td>
      <td>3.70</td>
      <td>0.86</td>
      <td>2</td>
      <td>3</td>
      <td>4</td>
      <td>5</td>
    </tr>
  </tbody>
</table>